J. Connor Wells

3.6k total citations
102 papers, 2.3k citations indexed

About

J. Connor Wells is a scholar working on Pulmonary and Respiratory Medicine, Cancer Research and Molecular Biology. According to data from OpenAlex, J. Connor Wells has authored 102 papers receiving a total of 2.3k indexed citations (citations by other indexed papers that have themselves been cited), including 52 papers in Pulmonary and Respiratory Medicine, 29 papers in Cancer Research and 26 papers in Molecular Biology. Recurrent topics in J. Connor Wells's work include Renal cell carcinoma treatment (48 papers), Cancer Genomics and Diagnostics (29 papers) and Renal and related cancers (21 papers). J. Connor Wells is often cited by papers focused on Renal cell carcinoma treatment (48 papers), Cancer Genomics and Diagnostics (29 papers) and Renal and related cancers (21 papers). J. Connor Wells collaborates with scholars based in Japan, Canada and United States. J. Connor Wells's co-authors include Toni K. Choueiri, Daniel Y.C. Heng, Frede Donskov, R. Fukagawa, Ha H. Bui, K. Sako, Georg A. Bjarnason, Benoit Beuselinck, Sumanta K. Pal and Takeshi Yuasa and has published in prestigious journals such as Journal of Clinical Oncology, Cancer and Clinical Cancer Research.

In The Last Decade

J. Connor Wells

96 papers receiving 2.2k citations

Peers

Countries citing papers authored by J. Connor Wells

Since Specialization

Citations

This map shows the geographic impact of J. Connor Wells's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J. Connor Wells with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J. Connor Wells more than expected).

Fields of papers citing papers by J. Connor Wells

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J. Connor Wells. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J. Connor Wells. The network helps show where J. Connor Wells may publish in the future.

Co-authorship network of co-authors of J. Connor Wells

This figure shows the co-authorship network connecting the top 25 collaborators of J. Connor Wells. A scholar is included among the top collaborators of J. Connor Wells based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J. Connor Wells. J. Connor Wells is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Impact of smoking status on clinical outcomes in patients with metastatic renal cell carcinoma treated with first-line immune checkpoint inhibitor-based regimens 2024 ·The Oncologist ·Eddy Saad, Georges Gebrael, (unknown), (unknown), Renée Maria Saliby, Chris Labaki, Nicolas Sayegh, J. Connor Wells, Kosuke Takemura, (unknown), (unknown), Naveen S. Basappa, Lori Wood, Thomas Powles, D. Scott Ernst, Aly‐Khan A. Lalani, Neeraj Agarwal, Wanling Xie, Daniel Y.C. Heng, Toni K. Choueiri	0
2	Outcomes of patients with advanced epithelial growth factor receptor mutant lung cancer treated with first-line osimertinib who would not have met the eligibility criteria for the FLAURA clinical trial 2024 ·Lung Cancer ·J. Connor Wells, (unknown), Cheryl Ho, Barbara Melosky, Janessa Laskin, (unknown), Sophie Sun	3
3	1902P Comparison of cabozantinib (CABO) versus sunitinib (SUN) following first-line (1L) nivolumab plus ipilimumab (NIVO+IPI) for metastatic renal cell carcinoma (mRCC): A target trial emulation using real-world data from the International mRCC Database Consortium (IMDC) 2023 ·Annals of Oncology ·(unknown), Kosuke Takemura, Devon J. Boyne, Matthew T. Warkentin, Darren R. Brenner, (unknown), J. Connor Wells, Chris Labaki, Bradley A. McGregor, (unknown), Luís Meza, Sumanta K. Pal, Benoit Beuselinck, Rana R. McKay, Bernadett Szabados, Thomas Powles, Takeshi Yuasa, Leopold Ludwig, Toni K. Choueiri, (unknown)	2
4	Characterizing progression to subsequent lines of therapy in metastatic renal cell carcinoma (mRCC) after nivolumab plus ipilimumab (Nivo+Ipi): Results from the International mRCC Database Consortium (IMDC). 2023 ·Journal of Clinical Oncology ·(unknown), Kosuke Takemura, (unknown), J. Connor Wells, (unknown), Camillo Porta, Guillermo de Velasco, Ian D. Davis, Lori Wood, Sumanta K. Pal, Aaron R. Hansen, Christian Kollmannsberger, Georg A. Bjarnason, Ben Tran, (unknown), Ravindran Kanesvaran, Thomas Powles, Rana R. McKay, Toni K. Choueiri, Daniel Yick Chin Heng	2
5	Outcomes of patients with advanced non-clear cell renal cell carcinoma treated with first-line immune checkpoint inhibitor therapy 2022 ·European Journal of Cancer ·Jeffrey Graham, J. Connor Wells, Shaan Dudani, Chun Loo Gan, Frede Donskov, Jae‐Lyun Lee, Christian Kollmannsberger, Luís Meza, Benoit Beuselinck, Aaron R. Hansen, Scott North, Georg A. Bjarnason, Nicolas Sayegh, Ravindran Kanesvaran, Lori Wood, Sébastien J. Hotte, Rana R. McKay, Toni K. Choueiri, Daniel Y.C. Heng	20
6	CABOSEQ: The Effectiveness of Cabozantinib in Patients With Treatment Refractory Advanced Renal Cell Carcinoma: Results From the International Metastatic Renal Cell Carcinoma Database Consortium (IMDC) 2022 ·Clinical Genitourinary Cancer ·Vishal Navani, J. Connor Wells, Devon J. Boyne, Winson Y. Cheung, Darren M. Brenner, Bradley A. McGregor, Chris Labaki, Andrew Schmidt, Rana R. McKay, Luís Meza, Sumanta K. Pal, Frede Donskov, Benoit Beuselinck, (unknown), Lisa Ludwig, Thomas Powles, Bernadett Szabados, Toni K. Choueiri, Daniel Y.C. Heng	12
7	Is Clinical Research Serving the Needs of the Global Cancer Burden? An Analysis of Contemporary Global Radiation Therapy Randomized Controlled Trials 2022 ·International Journal of Radiation OncologyBiologyPhysics ·(unknown), Wilma M. Hopman, J. Connor Wells, Yolande Lievens, Rozita Abdul Malik, C.S. Pramesh, Bishal Gyawali, Nazik Hammad, Deborah Mukherji, Richard Sullivan, Jeannette Parkes, Christopher M. Booth, Ajay Aggarwal	20
8	Interactive Data Visualization Tool for Patient-Centered Decision Making in Kidney Cancer 2021 ·JCO Clinical Cancer Informatics ·Kevin Shee, Sumanta K. Pal, J. Connor Wells, (unknown), (unknown), Shaan Dudani, Toni K. Choueiri, Daniel Yick Chin Heng, John L. Gore, Anobel Y. Odisho	1
9	Outcomes of patients with solid tumour malignancies treated with first-line immuno-oncology agents who do not meet eligibility criteria for clinical trials 2021 ·European Journal of Cancer ·Chun Loo Gan, Igor Stukalin, Daniel E. Meyers, Shaan Dudani, (unknown), (unknown), (unknown), (unknown), (unknown), J. Connor Wells, Aliyah Pabani, Tina Cheng, Jose Gerard Monzon, Don Morris, Naveen S. Basappa, Sumanta K. Pal, Lori Wood, Frede Donskov, Toni K. Choueiri, Daniel Y.C. Heng	32
10	Clinical Effectiveness of Second-line Sunitinib Following Immuno-oncology Therapy in Patients with Metastatic Renal Cell Carcinoma: A Real-world Study 2021 ·Clinical Genitourinary Cancer ·J. Connor Wells, Shaan Dudani, Chun Loo Gan, Igor Stukalin, Arun Azad, Elizabeth Liow, Frede Donskov, Takeshi Yuasa, Sumanta K. Pal, Guillermo de Velasco, Aaron R. Hansen, Benoit Beuselinck, Christian Kollmannsberger, Thomas Powles, Bradley A. McGregor, Mei Sheng Duh, Lynn Huynh, Daniel Y.C. Heng	11
11	Real-world clinical effectiveness of second-line sunitinib following immuno-oncology therapy in patients with metastatic renal cell carcinoma 2020 ·European Urology Open Science ·J. Connor Wells, Shaan Dudani, Gan Chen, Igor Stukalin, Arun Azad, Elizabeth Liow, Frede Donskov, Takeshi Yuasa, Sumanta K. Pal, Gloria Velasco, Laura D. Wood, Aaron R. Hansen, Benoit Beuselinck, Christian Kollmannsberger, (unknown), Bradley A. McGregor, Mei Sheng Duh, Lynn Huynh, D.Y.C. Heng	1
12	Deferred Cytoreductive Nephrectomy in Patients with Newly Diagnosed Metastatic Renal Cell Carcinoma 2020 ·European Urology ·Bimal Bhindi, Jeffrey Graham, J. Connor Wells, Ziad Bakouny, Frede Donskov, Anna Paola Fraccon, Felice Pasini, Jae‐Lyun Lee, Naveen S. Basappa, Aaron R. Hansen, Christian Kollmannsberger, Ravindran Kanesvaran, Takeshi Yuasa, D. Scott Ernst, Sandy Srinivas, Brian I. Rini, I. Alex Bowman, Sumanta K. Pal, Toni K. Choueiri, Daniel Y.C. Heng	42
13	Cytoreductive Nephrectomy in Metastatic Papillary Renal Cell Carcinoma: Results from the International Metastatic Renal Cell Carcinoma Database Consortium 2019 ·European Urology Oncology ·Jeffrey Graham, J. Connor Wells, Frede Donskov, Jae‐Lyun Lee, Anna Paola Fraccon, Felice Pasini, Camillo Porta, I. Alex Bowman, Georg A. Bjarnason, D. Scott Ernst, Sun Young Rha, Benoit Beuselinck, Aaron R. Hansen, Scott North, Christian Kollmannsberger, Lori Wood, Ulka N. Vaishampayan, Sumanta K. Pal, Toni K. Choueiri, Daniel Y.C. Heng	31
14	Clinical Outcomes of First-line Sunitinib Followed by Immuno-oncology Checkpoint Inhibitors in Patients With Metastatic Renal Cell Carcinoma 2019 ·Clinical Genitourinary Cancer ·J. Connor Wells, Jeffrey Graham, Benoit Beuselinck, Georg A. Bjarnason, Frede Donskov, Aaron R. Hansen, Rana R. McKay, Ulka N. Vaishampayan, Guillermo de Velasco, Mei Sheng Duh, Lynn Huynh, Catherine Nguyen, Giovanni Zanotti, Krishnan Ramaswamy, Toni K. Choueiri, Daniel Y.C. Heng	2
15	Disulfiram when Combined with Copper Enhances the Therapeutic Effects of Temozolomide for the Treatment of Glioblastoma 2016 ·Clinical Cancer Research ·Xueqing Lun, J. Connor Wells, Natalie Grinshtein, Jennifer C. King, Xiaoguang Hao, (unknown), Xiuling Wang, Asma M. Aman, David Uehling, Alessandro Datti, Jeffrey L. Wrana, Jacob C. Easaw, (unknown), Samuel Weiss, J. Gregory Cairncross, David R. Kaplan, Stephen M. Robbins, Donna L. Senger	169
16	Efficacy of Second-line Targeted Therapy for Renal Cell Carcinoma According to Change from Baseline in International Metastatic Renal Cell Carcinoma Database Consortium Prognostic Category 2016 ·European Urology ·Ian D. Davis, Wanling Xie, Carmel Pezaro, Frede Donskov, J. Connor Wells, Neeraj Agarwal, Sandy Srinivas, Takeshi Yuasa, Benoit Beuselinck, Lori Wood, D. Scott Ernst, Ravindran Kanesvaran, Jennifer J. Knox, Allan J. Pantuck, Sadia Saleem, Ajjai Alva, Brian I. Rini, Jae‐Lyun Lee, Toni K. Choueiri, Daniel Y.C. Heng	8
17	Cytoreductive Nephrectomy in Patients with Synchronous Metastases from Renal Cell Carcinoma: Results from the International Metastatic Renal Cell Carcinoma Database Consortium 2014 ·European Urology ·Daniel Y.C. Heng, J. Connor Wells, Brian I. Rini, Benoit Beuselinck, Jae‐Lyun Lee, Jennifer J. Knox, Georg A. Bjarnason, Sumanta K. Pal, Christian Kollmannsberger, Takeshi Yuasa, Sandy Srinivas, Frede Donskov, Aristotelis Bamias, Lori Wood, D. Scott Ernst, Neeraj Agarwal, Ulka N. Vaishampayan, Sun Young Rha, Jaeyeon Kim, Toni K. Choueiri	311
18	Versatile microfluidic total internal reflection (TIR)-based devices: Application to microbeads velocity measurement and single molecule detection with upright and inverted microscope 2008 ·Lab on a Chip ·Nam Cao Hoai Le, Ryuji Yokokawa, Dzung Viet Dao, Thien Nguyen, J. Connor Wells, Susumu Sugiyama	19
19	Direct measurement of fluid velocity gradients at a wall by PIV image processing with stereo reconstruction 2006 ·Journal of Visualization ·Chuong Nguyen, J. Connor Wells	11
20	Silicon piezoresistive six-degree of freedom force-moment micro sensor 2003 ·Sensors and Materials ·Dzung Viet Dao, Toshiyuki Toriyama, J. Connor Wells, Susumu Sugiyama	47

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact